Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel Transdermal Ketoprofen Gel Formulation for Knee Osteoarthritis
NCT07319728Phase 1Active, not recruiting
- Sponsor
- New Valley University
- Start
- May 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of Ketofen in osteoarthritis (OA) (2 arms), sponsored by New Valley University. Primary endpoints: Visual Analogue Scale at 2 weeks and McMaster Universities Arthritis Index at 2 weeks. Started May 2025; status: active, not recruiting.
02
Drugs
Ketofen
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07319728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07319728.